CAS 1629760-28-6
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 Produkte.
Ladiratuzumab
CAS:LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing anReinheit:98.2% (SEC-HPLC) - >95.0% (SDS-PAGE)Farbe und Form:LiquidMolekulargewicht:146.96 kDa
